07:00 , May 9, 2016 |  BioCentury  |  Product Development

Community organizers

With new papers published by the day and a flurry of big-dollar deals and financings, it's hard to separate the signal from the noise in the microbiome space. The space has become so hot that...
08:00 , Mar 7, 2016 |  BC Week In Review  |  Clinical News

Blautix: Completed Phase I enrollment

4D completed enrollment of 56 healthy volunteers and patients in a Phase I trial of Blautix. 4D Pharma plc (LSE:DDDD), Manchester, U.K.   Product: Blautix   Business: Gastrointestinal   Molecular target: NA   Description: Live...